Neuron Biolabs develops biosolutions for application in the pharmaceutical and agri-food industries through its specialised divisions

  • The Pharma division is dedicated fundamentally to the search for preventative drugs and treatments for neurodegenerative diseases, particularly Alzheimer’s disease.
  • The Diagnostic division develops tools and biomarkers for the diagnosis of diseases of the Central Nervous System, as in the case of Alzheimer’s.
  • The Services Division offers a wide range of R&D services in the fields of biomedicine, toxicology and agri-food.  Neuron Bio offers preclinical R&D services for the biomedicine, toxicological and agro-food areas, developing tailor-made projects through the use of in vitro and in vivo models (efficacy and safety, behavior studies …) in multiple areas of study.

Scientific Milestones

  • Pipeline consisting of 5 compounds for the central nervous system.
  • 5 patent families.
  • Discovery of 31 new molecules.
  • Implementation of a drug discovery platform.
  • Compound database consisting of 22,000 extracts.
  • Development of a diagnostic tool for Alzheimer’s Disease (AlzTEST®).

Este sitio web utiliza cookies para que usted tenga la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies, pinche el enlace para mayor información.plugin cookies

Aviso de cookies